CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE1315.051 (+0.08 %)
PREV CLOSE ( ) 1314.05
OPEN PRICE ( ) 1305.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4261
TODAY'S LOW / HIGH ( )1293.45 1322.35
52 WK LOW / HIGH ( )647.1 1617.8
NSE1311.70-4.8 (-0.36 %)
PREV CLOSE( ) 1316.50
OPEN PRICE ( ) 1318.00
BID PRICE (QTY) 1311.70 (7)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 72593
TODAY'S LOW / HIGH( ) 1290.00 1318.00
52 WK LOW / HIGH ( )646.8 1619.05

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.